This inventor holds 1 USPTO granted patent. Top assignee: Mochida Pharmaceutical Co., Ltd.. Active years: 1990.
Company Filing History:
Years Active: 1990
Title: **Kenji Toba: Pioneering Relief from Platinum-Containing Drug Side Effects**
Introduction
Kenji Toba, an innovative inventor based in Tokyo, Japan, has made a significant contribution to the field of pharmaceuticals. With a focus on improving patient outcomes, Toba has developed a unique pharmaceutical composition aimed at alleviating the severe side effects associated with platinum-containing drugs. His groundbreaking work demonstrates the potential for enhancing the safety and efficacy of cancer treatments.
Latest Patents
Kenji Toba holds one patent, which is a pharmaceutical composition designed to relieve side effects caused by platinum-based chemotherapy agents. Specifically, his patent addresses the serious issue of kidney dysfunction induced by drugs like cisplatin. The invention comprises an effective component of ulinastatin, which has shown potential in mitigating kidney-related complications experienced by patients undergoing platinum-based therapies.
Career Highlights
Toba's career is marked by his dedication to advancing pharmaceutical science, particularly in the oncology sector. His work at Mochida Pharmaceutical Co., Ltd. has positioned him as a key player in drug development, focusing on innovative solutions that prioritize patient well-being. Through his research, Toba has contributed to the understanding of how to better manage and reduce adverse effects in cancer patients.
Collaborations
Throughout his journey, Kenji Toba has collaborated with esteemed colleagues, including Toshio Sato and Yoshinosuke Fukuchi. These partnerships have facilitated a dynamic exchange of ideas and expertise, enhancing the overall quality of their research and leading to the successful development of new therapeutic approaches.
Conclusion
Kenji Toba's contributions to pharmaceutical innovation highlight the importance of addressing the challenges faced by patients undergoing cancer treatment. By focusing on alleviating the side effects of platinum-containing drugs, Toba's work not only benefits individual patients but also represents a significant advancement in the field of medicine. His commitment to collaboration and research excellence continues to pave the way for future innovations in healthcare.